A new method for long-range haplotype phasing with short-read sequencing data.

Information

  • Research Project
  • 9048335
  • ApplicationId
    9048335
  • Core Project Number
    R43HG008924
  • Full Project Number
    1R43HG008924-01
  • Serial Number
    008924
  • FOA Number
    PA-14-071
  • Sub Project Id
  • Project Start Date
    7/5/2016 - 8 years ago
  • Project End Date
    12/31/2017 - 6 years ago
  • Program Officer Name
    SMITH, MICHAEL
  • Budget Start Date
    7/5/2016 - 8 years ago
  • Budget End Date
    12/31/2017 - 6 years ago
  • Fiscal Year
    2016
  • Support Year
    01
  • Suffix
  • Award Notice Date
    7/4/2016 - 8 years ago
Organizations

A new method for long-range haplotype phasing with short-read sequencing data.

? DESCRIPTION (provided by applicant): A key challenge to the integration of genomics into the clinical setting is the ability to link genomic variation within a chromosome, i.e., to separat and characterize the two copies of a genome present in a diploid cell. This linkage process, known as haplotype phasing, is difficult to accomplish using the short­read, high­throughput sequencing technologies in routine use today. Haplotype phasing is critical for many clinical genomics interests, including linking compound heterozygote variants within disease­associated genes and untangling complex genomic rearrangements frequently found in cancers. Attempts to circumvent the limitations of short­read sequencing in haplotype phasing by using longer­read sequencing technology are in the early stages of development and years from routine use. Given the demand for haplotype phasing in the clinical setting, new approaches that can immediately leverage proven short­read sequencing technologies are needed. Dovetail Genomics has developed and generated preliminary feasibility data for a method that generates short­read sequencing libraries for phasing haplotypes. This technique promises more complete, contiguous, and accurate haplotype characterization than existing approaches, and does so simply and affordably. In order to successfully develop the concept and continue to demonstrate feasibly, the following two goals will be met: First computational models will be used to determine the parameters required for haplotype phasing with the method, and these parameters will be tested and adjusted. Second, the method's capacity to phase haplotypes and reconstruct reference genome standards at high accuracy and completeness will be tested. Successful demonstration of feasibility will permit further development of the method with the goal of developing a commercially viable kit and complementary software analysis suite for clinical genomics.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R43
  • Administering IC
    HG
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    149786
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:149786\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DOVETAIL GENOMICS, LLC
  • Organization Department
  • Organization DUNS
    079097900
  • Organization City
    SANTA CRUZ
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    950605756
  • Organization District
    UNITED STATES